Spravato is a nasal spray that contains esketamine, a potent form of ketamine. Ketamine has been used for years as an anesthetic, and recent studies have shown it has powerful antidepressant effects. By targeting the NMDA receptors Spravato helps restore the balance of brain chemicals and can deliver fast relief for patients with TRD.
Spravato is administered in a supervised medical setting to ensure safety. Typically, patients will receive their first few doses at a clinic, where medical staff can monitor them for side effects.
If you or someone you know is struggling with treatment-resistant depression, Spravato could be the breakthrough treatment you've been looking for.